CYP19A1 and Infertility: In general agreement with this assumption, we found that both the aromatase inhibitor treatment, as well as crossings of AROM+ with ERαKO, not only, as expected, rescued the infertile phenotype [6,42] and reverted macrophage and inflammation markers, but also reduced TRPV2 and NOX2 levels.